Lipid-DNA Nanoparticles as Drug-Delivery Vehicles for the Treatment of Retinal Diseases

Retinal eye diseases are the leading cause of blindness in the Western world. Up to date, the only efficient treatment for many retinal diseases consists of invasive intravitreal injections of highly concentrated drugs. Despite the fact that these injections are unpleasant for the patients, they pot...

Descripción completa

Detalles Bibliográficos
Autores principales: Schnichels, Sven, Simmang, David, Löscher, Marina, Herrmann, Andreas, de Vries, Jan Willem, Spitzer, Martin S., Hurst, José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961589/
https://www.ncbi.nlm.nih.gov/pubmed/36839853
http://dx.doi.org/10.3390/pharmaceutics15020532

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961589/
https://www.ncbi.nlm.nih.gov/pubmed/36839853
http://dx.doi.org/10.3390/pharmaceutics15020532

Ejemplares similares